CJC-1295 (No DAC) is a tetrasubstituted growth hormone–releasing hormone (GHRH) analog designed for short-acting, pulsatile research models. Ipamorelin is a selective growth hormone–releasing peptide (GHRP) studied for its high specificity to ghrelin receptors and minimal off-target activity.

In laboratory research, this combination is frequently evaluated to examine dual GHRH + GHRP signaling effects on growth hormone (GH) secretion, pituitary signaling, IGF-1 pathway activation, and broader endocrine axis responses. The blend allows researchers to study how coordinated receptor activity influences metabolic, endocrine, and cellular processes.

This compound is supplied exclusively as sterile lyophilized powder for laboratory research use and is not intended for human or veterinary applications.

Potential Research Applications

• GH pulse frequency modeling

• GHRH + GHRP receptor synergy studies

• Pituitary signaling pathways

• IGF-1 pathway stimulation

• Endocrine axis response mapping

• Cellular signaling cascade evaluation

Peptide Characteristics

• Form: Lyophilized powder

• Appearance: White powder

• Purity: ≥98%

• Class: GHRH analog + GHRP research combination

Storage Guidelines

• Store lyophilized material at −20 °C for long-term preservation

• Short-term storage: 2–8 °C

• Protect from light and moisture

• Reconstitute using laboratory-grade solvent only

• Do not freeze after reconstitution

Reconstitution

Reconstitute using appropriate laboratory-grade solvent under sterile research conditions. Dissolve gently according to experimental protocol requirements.

Research Use Disclaimer

• For laboratory research use only

• Not for human consumption

• Not for medical, therapeutic, or diagnostic use

• Not a drug, food, or dietary supplement

• Proper research qualifications required